Generation of two induced pluripotent stem cell lines, SHIPMi001-A from a patient with hypertrophic cardiomyopathy caused by MYBPC3 gene mutation and SHIPMi002-A from a healthy male individual

Summary

Hypertrophic cardiomyopathy is a hereditary disease with high incidence of sudden death and heart failure. Myosin-binding protein C3 (MYBPC3) is the most commonly mutation gene. Here, we report the establishment of two human induced pluripotent stem cell (iPSC) lines: one from a patient carrying a heterozygous c.1377delC mutation in MYBPC3 (c.1377delC: p.L460Wfs) and one from a healthy donor. The generated iPSC lines showed comparable pluripotent genes, demonstrated the capacity to differentiate into derivatives of all three germ layers and normal karyotypes. These lines are valuable for the mechanism research and drug development of hypertrophic cardiomyopathy. Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Authors Wang Y, Xiong W, Zhao S, Li B, Chang ACY
Journal Stem cell research
Publication Date 2021 Nov 10;57:102594
PubMed 34785479
DOI 10.1016/j.scr.2021.102594

Research Projects

Cell Lines